Expression of IL‐10‐triggered STAT3‐dependent IL‐4Rα is required for induction of arginase 1 in visceral leishmaniasis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Journal of Immunology

• Publication date

  2011-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.201040940PMID 21413004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MAPK‐directed phosphatases preferentially regulate pro‐ and anti‐inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase C isoforms

  2010cited by this paper
• Arginase II Restricts Host Defense to Helicobacter pylori by Attenuating Inducible Nitric Oxide Synthase Translation in Macrophages

  2010cited by this paper
• Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB/c mice.

  2009cited by this paper
• Signaling events leading to the curative effect of cystatin on experimental visceral leishmaniasis: Involvement of ERK1/2, NF‐κB and JAK/STAT pathways

  2009cited by this paper
• Role of intracellular cAMP in differentiation-coupled induction of resistance against oxidative damage in Leishmania donovani.

  2008cited by this paper
• Arginase modulates Salmonella induced nitric oxide production in RAW264.7 macrophages and is required for Salmonella pathogenesis in mice model of infection.

  2008cited by this paper
• Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens

  2008cited by this paper
• Dominant arginase expression in a model of progressive visceral leishmaniasis

  2008cited by this paper
• CD4+CD25−Foxp3− Th1 cells are the source of IL-10–mediated immune suppression in chronic cutaneous leishmaniasis

  2007cited by this paper
• An Effect of Parasite-Encoded Arginase on the Outcome of Murine Cutaneous Leishmaniasis1

  2007cited by this paper
• Arginase I Induction during Leishmania major Infection Mediates the Development of Disease

  2005cited by this paper
• Cutting Edge: IL-10-Independent STAT3 Activation by Toxoplasma gondii Mediates Suppression of IL-12 and TNF-α in Host Macrophages1

  2005cited by this paper
• Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta.

  2005cited by this paper
• 18 Beta-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-kappa B.

  2005cited by this paper
• Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo

  2005cited by this paper
• IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-alpha in host macrophages.

  2005cited by this paper
• T helper (h)1/Th2 and Leishmania: paradox rather than paradigm.

  2005cited by this paper
• 18β-Glycyrrhetinic Acid Triggers Curative Th1 Response and Nitric Oxide Up-Regulation in Experimental Visceral Leishmaniasis Associated with the Activation of NF-κB1

  2005cited by this paper
• STAT3 activation in macrophages following infection with Salmonella.

  2004cited by this paper
• Enhancer-Mediated Control of Macrophage-Specific Arginase I Expression1

  2004cited by this paper
• Inducible nitric oxide synthase and control of intracellular bacterial pathogens.

  2003cited by this paper
• The many faces of macrophage activation

  2003cited by this paper
• Arginase I induction in macrophages, triggered by Th2‐type cytokines, supports the growth of intracellular Leishmania parasites

  2002cited by this paper
• Type 1 and type 2 responses to Leishmania major.

  2002cited by this paper
• Helicobacter pylori Induces Macrophage Apoptosis by Activation of Arginase II1

  2002cited by this paper
• Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite

  2002cited by this paper
• Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101

  2002cited by this paper
• The Inhibition of Arginase by N ω-Hydroxy-l-Arginine Controls the Growth of Leishmania Inside Macrophages

  2001cited by this paper
• Arginase expression in peritoneal macrophages and increase in circulating polyamine levels in mice infected with Schistosoma mansoni

  2001cited by this paper
• Successful Therapy of Lethal Murine Visceral Leishmaniasis with Cystatin Involves Up-Regulation of Nitric Oxide and a Favorable T Cell Response1

  2001cited by this paper
• Cutting Edge: Stat6-Dependent Substrate Depletion Regulates Nitric Oxide Production1

  2001cited by this paper
• IL‐10 mediates susceptibility to Leishmania donovani infection

  2001cited by this paper
• IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells.

  2000cited by this paper
• Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells.

  1999cited by this paper
• IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains.

  1999cited by this paper
• The IL-4 receptor: signaling mechanisms and biologic functions.

  1999cited by this paper
• Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

  1999cited by this paper
• Arginine metabolism: nitric oxide and beyond.

  1998cited by this paper
• Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype.

  1998cited by this paper
• Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.

  1997cited by this paper
• Comparative properties of arginases.

  1996cited by this paper
• Susceptibility to Leishmania major Infection in Interleukin-4-Deficient Mice

  1996cited by this paper
• Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow‐derived macrophages by TH 1 and TH 2 cytokines

  1995cited by this paper
• Determination of arginase activity in macrophages: a micromethod.

  1994cited by this paper

• Leishmania mediated regulation of host metabolism: impact on host immunity.

  2026cites this paper
• Drug Repurposing for Kala-Azar

  2025cites this paper
• Glucocorticoid Receptor-Targeted Nanoliposome for STAT3 Inhibition-Led Myeloid-Derived Suppressor Cell Modulation and Efficient Colon Cancer Treatment.

  2025cites this paper
• Reciprocal interactions between glioma and tissue-resident cells fueling tumor progression.

  2025cites this paper
• Leishmania exploits host cAMP/EPAC/calcineurin signaling to induce an IL-33–mediated anti-inflammatory environment for the establishment of infection

  2024cites this paper
• Anti-leishmanial therapies: overcoming current challenges with emerging therapies

  2024cites this paper
• Hydrogen Attenuates Inflammation by Inducing Early M2 Macrophage Polarization in Skin Wound Healing

  2023cites this paper
• IL-6/ERK signaling pathway participates in type I IFN-programmed, unconventional M2-like macrophage polarization

  2023cites this paper
• Organ‐specific immune profiling of Leishmania donovani‐infected hamsters

  2022cites this paper
• Cytokines and Signaling Networks Regulating Disease Outcomes in Leishmaniasis

  2022cites this paper
• IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections

  2021cites this paper
• Ex Vivo Phenotypic Screening of Two Small Repurposing Drug Collections Identifies Nifuratel as a Potential New Treatment against Visceral and Cutaneous Leishmaniasis.

  2021cites this paper
• Arginase and its mechanisms in Leishmania persistence

  2020cites this paper
• Macrophages as host, effector and immunoregulatory cells in leishmaniasis: Impact of tissue micro-environment and metabolism

  2020cites this paper
• Use of IL-6-elafin genetically modified regulatory macrophages as an immunotherapeutic against acute bacterial infection in the lung

  2020cites this paper
• Differential Regulation of l-Arginine Metabolism through Arginase 1 during Infection with Leishmania mexicana Isolates Obtained from Patients with Localized and Diffuse Cutaneous Leishmaniasis

  2020cites this paper
• Leishmania donovani Subverts Host Immune Response by Epigenetic Reprogramming of Macrophage M(Lipopolysaccharides + IFN-γ)/M(IL-10) Polarization

  2020cites this paper
• Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy

  2019cites this paper
• Parasitic load determination by differential expression of 5-Lipoxygenase and PGE2 Synthases in Visceral Leishmaniasis.

  2019cites this paper
• Ammonium trichloro [1,2-ethanediolato-O,O′]-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K/Akt pathway

  2018cites this paper
• Alteration of microRNA 340-5p and Arginase-1 Expression in Peripheral Blood Cells during Acute Ischemic Stroke

  2018cites this paper
• Epigenetic modulation of macrophage polarization- perspectives in diabetic wounds.

  2018cites this paper
• Host-Directed Drug Therapies for Neglected Tropical Diseases Caused by Protozoan Parasites

  2018cites this paper
• Leptin regulates Granzyme-A, PD-1 and CTLA-4 expression in T cell to control visceral leishmaniasis in BALB/c Mice

  2017cites this paper
• Mahanine exerts in vitro and in vivo antileishmanial activity by modulation of redox homeostasis

  2017cites this paper
• The AP-1 Transcription Factor c-Jun Promotes Arthritis by Regulating Cyclooxygenase-2 and Arginase-1 Expression in Macrophages

  2017cites this paper
• TonEBP suppresses IL-10-mediated immunomodulation

  2016cites this paper
• IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration.

  2015cites this paper
• Lysophosphatidylcholine exacerbates Leishmania major-dendritic cell infection through interleukin-10 and a burst in arginase1 and indoleamine 2,3-dioxygenase activities.

  2015cites this paper
• Growth Factor and Th2 Cytokine Signaling Pathways Converge at STAT6 to Promote Arginase Expression in Progressive Experimental Visceral Leishmaniasis

  2014cites this paper
• The Quality of Methods Reporting in Parasitology Experiments

  2014cites this paper
• Macrophage Polarization Drives Granuloma Outcome during Mycobacterium tuberculosis Infection

  2014cites this paper
• Differential microglial activation in neurodegenerative diseases

  2013cites this paper
• Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis.

  2013cites this paper
• HDL Induces the Expression of the M2 Macrophage Markers Arginase 1 and Fizz-1 in a STAT6-Dependent Process

  2013cites this paper
• Infection-induced IL-10 and JAK-STAT

  2012cites this paper
• Electroacupuncture at the ST36 acupoint increases interleukin-4 responsiveness in macrophages, generation of alternatively activated macrophages and susceptibility to Leishmania major infection

  2012cites this paper
• Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis

  2012cites this paper
• TLR‐mediated distinct IFN‐γ/IL‐10 pattern induces protective immunity against murine visceral leishmaniasis

  2012cites this paper
• Progressive Visceral Leishmaniasis Is Driven by Dominant Parasite-induced STAT6 Activation and STAT6-dependent Host Arginase 1 Expression

  2012influential citation
• Infection-induced IL-10 and Jak-Stat: A review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes

  2012cites this paper